Efficacy and safety of glecaprevir and pibrentasvir combination therapy in old-aged patients with chronic hepatitis C virus infection

Objective: Combination therapy with glecaprevir and pibrentasvir (G/P) has been shown to provide a sustained virologic response (SVR) rate of >97% in patients with chronic hepatitis C virus (HCV) infection in the first published real-world Japanese data. However, a recently published study showed...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Shunji, Morimoto, Naoki, Miura, Kouichi, Murohisa, Toshimitsu, Tahara, Toshiyuki, Sato, Takashi, Tano, Shigeo, Fukaya, Yukimura, Kurata, Hidekazu, Okamura, Yukishige, Numao, Norikatsu, Uehara, Keita, Murayama, Kozue, Nakazawa, Katsuyuki, Sugaya, Hitoshi, Yoshizumi, Hiroaki, Iijima, Makoto, Tsukui, Mamiko, Hirosawa, Takuya, Takaoka, Yoshinari, Nomoto, Hiroaki, Maeda, Hiroshi, Goka, Rie, Isoda, Norio, Yamamoto, Hironori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Association of Rural Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530586/
https://www.ncbi.nlm.nih.gov/pubmed/33033533
http://dx.doi.org/10.2185/jrm.2020-004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530586/
https://www.ncbi.nlm.nih.gov/pubmed/33033533
http://dx.doi.org/10.2185/jrm.2020-004

Ejemplares similares